Downregulation of NOP56 expression significantly inhibited the proliferation of KRAS mutant lung, pancreatic and colorectal cancer cells, and NOP56 mRNA levels have been suggested to be a predictive marker of rapamycin sensitivity (IC50) in KRAS mutant cancers (10). This evidence concerns the gene KRAS and cancer.